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Abstract
Background: Affecting the core functional microbiome, peculiar high level taxonomic unbalances of the human 
intestinal microbiota have been recently associated with specific diseases, such as obesity, inflammatory bowel 
diseases, and intestinal inflammation.
Results: In order to specifically monitor microbiota unbalances that impact human physiology, here we develop and 
validate an original DNA-microarray (HTF-Microbi.Array) for the high taxonomic level fingerprint of the human 
intestinal microbiota. Based on the Ligase Detection Reaction-Universal Array (LDR-UA) approach, the HTF-
Microbi.Array enables specific detection and approximate relative quantification of 16S rRNAs from 30 phylogenetically 
related groups of the human intestinal microbiota. The HTF-Microbi.Array was used in a pilot study of the faecal 
microbiota of eight young adults. Cluster analysis revealed the good reproducibility of the high level taxonomic 
microbiota fingerprint obtained for each of the subject.
Conclusion: The HTF-Microbi.Array is a fast and sensitive tool for the high taxonomic level fingerprint of the human 
intestinal microbiota in terms of presence/absence of the principal groups. Moreover, analysis of the relative 
fluorescence intensity for each probe pair of our LDR-UA platform can provide estimation of the relative abundance of 
the microbial target groups within each samples. Focusing the phylogenetic resolution at division, order and cluster 
levels, the HTF-Microbi.Array is blind with respect to the inter-individual variability at the species level.
Background
Human beings have been recently reconsidered as super-
organisms in co-evolution with an immense microbial
community living in the gastrointestinal tract (GIT), the
human intestinal microbiota [1,2]. Providing important
metabolic functions that we have not evolved by our own
[3], the intestinal microbiota has a fundamental role for
the human health and well being [4,5]. Several of our
physiological features, such as nutrient processing, matu-
ration of the immune system, pathogen resistance, and
development of the intestinal architecture, strictly
depend on the mutualistic symbiotic relationship with
the intestinal microbiota [6]. On the basis of its global
impact on human physiology, the intestinal microbiota
has been considered an essential organ of the human
body [7].
The composition of the adult intestinal microbiota has
been determined in three large scale 16S rRNA sequences
surveys [7-11]. The phylogenetic analysis of a total of
45,000 bacterial 16S rRNA data from 139 adults revealed
that, at the phylum level, only a small fraction of the
known bacterial diversity is represented in our GIT. The
vast majority of bacteria in the human intestinal microbi-
ota (>99%) belongs to six bacterial phyla: Firmicutes,
Bacteroidetes, Actinobacteria, Proteobacteria, Fusobacte-
ria and Verrucomicrobia. The two dominant divisions are
Firmicutes  and  Bacteroidetes, which represent together
up to 90% of the total microbiota, with a relative abun-
dance of 65% and 25%, respectively. Actinobacteria, Pro-
teobacteria, Verrucomicrobia and  Fusobacteria  are the
subdominants phyla with a relative abundance up to 5, 8,
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2 and 1%, respectively. On the contrary, at lower taxo-
nomic levels, we assist to a real explosion of the bacterial
diversity in the human GIT. At least 1,800 genera [≥ 90%
of sequence identity (ID)] and 16,000 phylotypes at the
species level (≥ 97% ID) have been identified until now,
predicting even a greater diversity at the species level [8].
Since 70% of these phylotypes are subject-specific, and no
phylotype is present at more than 0.5% abundance in all
subjects [12], the intestinal microbiota of each individual
has been shown to consist in a subject specific comple-
ment of hundreds of genera and thousands of species.
However, the large degree of functional redundancy
between species and genera allowed identifying a core
microbiome at the gene level which is shared between all
individuals [12]. Coding for genes involved in important
metabolic functions, this core functional microbiome is
fundamental to support the mutualistic symbiotic rela-
tionship with the human host.
Recently, 16S rRNA sequences studies have been car-
ried out with the attempt to describe disease-associated
unbalances of the human intestinal microbiota. Even
though species variability was associated with inter-indi-
vidual variability, phylum-level changes of the intestinal
microbiota were associated with specific diseases. In par-
ticular, obesity was characterized by a higher proportion
of Firmicutes and Actinobacteria with respect to Bacte-
roidetes and an overall reduced bacterial diversity [12,13].
Differently, inflammatory bowel diseases (IBD) were
characterized by a marked reduction of bacterial diversity
in the Clostridium cluster IV and XIVa belonging to Fir-
micutes, a decline in Bacteroidetes biodiversity, and a cor-
respondent increase in Proteobacteria  and  Bacillus
[14,15]. Analogously, intestinal inflammation has been
generally related with a marked increase in Enterobacteri-
aceae and a correspondent decrease in members of the
resident colonic bacteria [16,17]. In the light of these
findings, it has been recently hypothesized that these
high level taxonomic unbalances of the human intestinal
microbiota can cause deviations from the core functional
microbiome with a final impact on the host physiological
state [12,18,19].
Since more than 75% of the phylotypes detected in the
human GIT does not correspond to cultured species [20],
phylogenetic DNA-microarrays have been recognized as
a valuable tool for a high-throughput, quantitative and
systematic analysis of the human intestinal microbiota
[21]. Recently, three different small ribosomal subunit
RNA (SSU rRNA) based high-density phylogenetic
microarrays for studying the human microbiota have
been developed [22-24]. Targeting thousands bacterial
phylo-types, these DNA-microarrays have been success-
fully applied in studies for the deep phylogenetic charac-
terization of the human intestinal microbiota.
In order to specifically monitor the microbiota unbal-
ances that impact on human physiology independently of
the inter-individual variability, here we developed an
original DNA-microarray for the high taxonomic level
fingerprint of the human intestinal microbiota, called
HTF-Microbi.Array (High Taxonomic Fingerprint
Microbiota Array). The relatively low number of targets
allowed implementing the Ligase Detection Reaction
(LDR) technology [25,26] for the development of the
HTF-Microbi.Array. This enzymatic in vitro reaction,
based on the discriminative properties of the DNA liga-
tion enzyme, requires the design of a pair of two adjacent
oligonucleotides specific for each target sequence: a
probe specific for the variation (called "Discriminating
Probe", or DS) which carries a 5'-fluorescent label, and a
second probe, named "Common Probe" (or CP), starting
one base 3'-downstream of the DS that carries a 5'-phos-
phate group and a unique sequence named cZipCode at
its 3'-end. The oligonucleotide probe pairs and a thermo-
stable DNA ligase are used in a LDR reaction with previ-
ously PCR-amplified DNA fragments. This reaction is
cycled to increase product yield. The LDR products,
obtained only in presence of a perfectly matching tem-
plate by action of the DNA ligase, are addressed to a pre-
cise location onto a Universal Array (UA), where a set of
artificial sequences, called Zip-codes are arranged. These
products carry both the fluorescent label and a unique
cZipCode sequence and can be detected by laser scan-
ning and identified according to their location within the
array. The LDR approach is a highly specific and sensitive
assay for detecting single nucleotide variations; thus, dif-
ferences of a single base along the 16S rRNA gene can be
employed to distinguish among different microbial lin-
eages. The HTF-Microbi.Array was successfully tested in
a pilot study for the characterization of the faecal micro-
biota of eight healthy young adults.
Results
Target selection and probe design
The rational selection of the HTF-Microbi.Array targets
was carried out using a phylogenetic approach. To this
aim we implemented the 16S rRNA database of the ARB
Project (release February, 2005) with the 16S rRNA gene
database of the RDP available at the time and a phyloge-
netic tree was constructed. Based on the tree nodes, 30
phylogenetical groups of the human intestinal microbiota
were rationally selected as the target group for the HTF-
Microbi.Array (Additional file 1). In Fig. 1 we report the
phylogenetic tree of the 16S rRNA sequences of the HTF-
Microbi.Array positive set. The selected groups belonged
to different phylogenetic levels (species, genus, family,
cluster, or group of species indicated by the warding "et
rel."). The entire list of the array targets is represented in
Table 1. For part of the division Firmicutes, the targetCandela et al. BMC Microbiology 2010, 10:116
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Figure 1 SSU rRNA based phylogenetic tree of the 16S rRNA sequences of the HTF-Microbi.Array positive set. For each node we report the 
number of sequences used from our ARB 16S rRNA sequence database. The triangles dimension is proportional to the number of sequences clustered 
together. The phylogenetic tree was obtained by using the neighbour-joining algorithm for the sequence alignment in ARB software.Candela et al. BMC Microbiology 2010, 10:116
http://www.biomedcentral.com/1471-2180/10/116
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Table 1: Probe set of the HTF-Microbi.Array.
PROBE N. TAXONOMIC 
LEVEL
CLUSTER ORDER DIVISION ECO H.G. 
AB %
Bacteroides/
Prevotella
16 Cluster Bacteroides/
Prevotella
Bacteroidales Bacteroidetes M2 0
Ruminococcus 
bromii
38 Sub cluster Cl IV Clostridiales Firmicutes M
Ruminococcus albus 39 Sub cluster Cl IV Clostridiales Firmicutes M
Faecalibacterium 
prausnitzii
40 Sub cluster Cl IV Clostridiales Firmicutes M
Oscillospira 
guillermondii
41 Sub cluster Cl IV Clostridiales Firmicutes M6 5
Clostridium IX 37 Cluster Cl IX Clostridiales Firmicutes M
Veilonella 20 Species (et rel)C l  I X Clostridiales Firmicutes M
Clostridium XIVa 22 Cluster Cl XIVa Clostridiales Firmicutes M
Eubacterium rectale 19 Species (et rel)C l  X I V a Clostridiales Firmicutes M
Bifidobacteriaceae 25B Family Bifidobacterium Bifidobacteriales Actinobacteria M5
B. longum 3S p e c i e s  ( et rel) Bifidobacterium Bifidobacteriales Actinobacteria M
Lactobacillaceae 21B Family Lactobacillaceae Lactobacillales Firmicutes M
L. plantarum 33 Species (et rel) Lactobacillaceae Lactobacillales Firmicutes M< 1
L. casei 12 Species (et rel) Lactobacillaceae Lactobacillales Firmicutes M
L. salivarius 14 Species (et rel) Lactobacillaceae Lactobacillales Firmicutes M
Bacillus clausii 32 Species (et rel) Bacillaceae Bacillales Firmicutes M< 1
Bacillus subtilis 8S p e c i e s  ( et rel) Bacillaceae Bacillales Firmicutes M< 1
Fusobacterium 15 Genus Fusobacteriaceae Fusobacteria Fusobacteria M< 0 . 5
Cyanobacteria 42 Family Cyanobacteria Cyanobacteria Cyanobacteria M< 0 . 1
Clostridium XI 36 Cluster Cl XI Clostridiales Firmicutes O0
Clostridium difficile 18 Species (et rel)C l  X I Clostridiales Firmicutes O
Clostridium I and II 35 Cluster Cl I and II Clostridiales Firmicutes O0
Clostridium 
perfringens
17 Species (et rel) Cl I and II Clostridiales Firmicutes O
Enterococcus 
faecalis
9S p e c i e s  ( et rel) Enterococcales Lactobacillales Firmicutes O< 1
Enterococcus 
faecium
10 Species (et rel) Enterococcales Lactobacillales Firmicutes O< 1Candela et al. BMC Microbiology 2010, 10:116
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selection was carried out based on the classification pro-
posed by Collins et al. [27]. Clostridium cluster I and II,
Clostridium  cluster IX, Clostridium  cluster XI, and
Clostridium cluster XIVa were selected. For the Clostrid-
ium cluster IV, four subgroups of species were defined:
Ruminococcus albus et rel., Ruminococcus bromii et rel.,
Faecalibacterium prausnitzii et rel., and Oscillospira
guillermondii et rel. Within the Firmicutes division, the
family Lactobacillaceae, and the groups Bacillus clausii et
rel., Bacillus subtilis et rel., Bacillus cereus et rel., Entero-
coccus faecalis et rel., and Enterococcus faecium et rel.
were also selected. Other selected groups were the Bacte-
roides/Prevotella  cluster (division Bacteroidates), the
family  Bifidobacteriaceae  (division  Actinobacteria), the
family Enterobacteriaceae and the genus Campylobacter
(division  Proteobacteria). For clusters or families, rele-
vant species, genera or subgroups of species were
selected to design "sub-probes". The genus Veillonella
was selected for Clostridium  cluster IX, the species
Eubacterium rectale for  Clostridium  cluster XIVa,
Clostridium difficile for  Clostridium  cluster XI, and
Clostridium perfringens for Clostridium cluster I and II.
The group Bifidobacterium longum et rel. was chosen for
the family Bifidobacteriaceae, and the genera Yersinia
and Proteus for the Enterobacteriaceae. Based on an orig-
inal phylogenetic design, the entire probe set of the HTF-
Microbi.Array cover up to 95% of the bacterial groups
belonging to the human intestinal microbiota [28].
Specificity and coverage of each candidate probe was
assessed by using the tool Probe Match of the RDP data-
base. The probe pairs selected for the HTF-
Microbi.Array were required to perfectly match the
sequences of the positive set and to possess at least a mis-
match at the 3' end of the discriminating probe respect to
the entire negative set. The designed probes pairs had an
average melting temperature (Tm) of 67.8 ± 0.9°C (n = 60)
and an average length of 35.6 ± 4.9 nucleotides. Sixteen
out of the 30 probe pairs were characterized by having no
degenerated bases, whereas only one probe pair (i.e. the
one for Clostridium cluster I and II) had 4 and 3 ambigu-
ous bases on DS and CP, respectively (Additional file 2).
Validation of the HTF-Microbi.Array
LDR probe pair specificity
The specificity of the designed LDR probe pairs was
tested by using 16S rRNA PCR amplicons from 28 micro-
organisms members of the human intestinal microbiota.
Amplicons were prepared by amplification of genomic
DNA extracted from DSMZ cultures or genomic DNA
from ATCC collection. Proving the specificity of the
HTF-Microbi.Array all the 16S rRNA amplicons were
properly recognized in separate LDR hybridization reac-
tions with the entire probe set of the array. Two replicated
independent LDR-UA experiments were performed with
an optimal reproducibility (Additional file 3). For each of
the 16S rRNA template only group-specific spots, and
spots corresponding to the hybridization controls
showed positive signals (P < 0.01) (Table 2). As a negative
control, we performed two independent PCR-LDR-UA
experiments using double distilled water, instead of
genomic DNA, as sample. As expected, no positive signal
was detected. The ratio between the signal intensities of
the specific probes and the blank intensity (SNRs) aver-
aged 206.9 ± 185.7, whereas the ratio between all the
other probes and the blank intensity (SNRns) averaged 2.1
± 1.4. Therefore, the ratio between specific and non-spe-
cific probes resulted more than 100 fold on average.
Evaluation of the LDR sensitivity and relative abundance 
detection level
In order to define the detection limits of the HTF-
Microbi.Array, LDR-UA experiments were carried out
with different concentrations of an artificial mix of 16S
rRNA amplicons from 6 members of the human intestinal
microbiota. The 16S rRNA amplicons from Bacillus
cereus, Lactobacillus casei, Bifidobacterium adolescentis,
Ruminococcus albus, Prevotella, Y. enterocolitica were all
specifically recognized in a range of concentrations from
0.7 to 75 fmol (P < 0.01), demonstrating the high sensitiv-
ity and specificity of the array (Fig. 2). Subsequently, in
Bacillus cereus 7S p e c i e s  ( et rel) Bacillaceae Bacillales Firmicutes P0
Enterobacteriaceae 23B Family Enterobacteraceae Enterobacterales Proteobacteria O/P <8
Yersinia 
enterocolitica
4S p e c i e s  ( et rel) Enterobacteraceae Enterobacterales Proteobacteria O/P 0
Proteus 5G e n u s Enterobacteraceae Enterobacterales Proteobacteria O/P 0
Campylobacter 6G e n u s Campylobacteraceae Campylobacterales Proteobacteria P0
For each probe is indicated the spot number, the phylogenetic level, the phylogeny of the target group, the ecology in the gastrointestinal 
ecosystem [mutualistic (M), opportunistic (O), pathogen (P)]. The relative abundance in a healthy gut ecosystem of the principal microbial 
groups is also indicated.
Table 1: Probe set of the HTF-Microbi.Array. (Continued)Candela et al. BMC Microbiology 2010, 10:116
http://www.biomedcentral.com/1471-2180/10/116
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Table 2: Specificity test.
DNA Target Positive signal SNR other SNR spec p-valus spec
B. fragilis ATCC25285 Bacterodes/Prevotella 0.85 30.81 9.35E-05
0.53 21.45 7.39E-04
B. thetaiotaomicrom 
ATCC29143
Bacterodes/Prevotella 0.45 61.44 2.56E-04
1.66 347.24 9.10E-06
L. gasseri DSM20243 Lactobacillaceae 0.30 5.58 4.98E-03
1.56 20.59 6.58E-03
P. melaninogenica 
ATCC25845
Bacterodes/Prevotella 1.54 480.24 6.02E-08
0.90 266.63 3.74E-09
B. subtilis DSM704 Bacillus subtilis 7.93 637.39 1.56E-09
5.62 350.10 1.47E-05
E. coli ATCC11105 Enterobacteriaceae 3.27 555.04 8.65E-08
2.59 222.39 4.50E-07
P. mirabilis DSM4479 Proteus, 
Enterobacteriaceae
2.42 703.22 7.74E-09
2.03 497.10 1.97E-09
B. bifidum DSM20456 Bifidobacteriaceae 2.67 289.39 4.78E-11
2.23 407.10 2.40E-08
L. casei DSM20011 Lactobacillaceae, L. 
casei
2.59 125.13 1.01E-04
2.26 134.78 5.92E-04
Y. enterocolitica (faecal 
isolate)
Yersinia enterocolitica, 
Enterobacteriaceae
1.53 231.33 1.01E-05
2.89 340.20 1.61E-06Candela et al. BMC Microbiology 2010, 10:116
http://www.biomedcentral.com/1471-2180/10/116
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B. cereus DSM31 Bacillus cereus 2.83 193.85 1.53E-06
2.49 196.82 4.16E-03
B. adolescentis 
ATCC15703
Bifidobacteriaceae 4.10 732.95 3.95E-10
2.90 338.59 5.59E-07
L. ramnosus DSM20021 Lactobacillaceae, L. 
casei
2.40 101.76 1.41E-03
4.23 177.70 4.62E-07
L. delbrueckii 
DSM20074
Lactobacillaceae 3.77 210.11 2.24E-08
3.10 121.93 6.27E-08
L. pentosus DSM20314 Lactobacillaceae 3.05 131.65 4.58E-09
1.63 58.30 5.32E-07
L. acidophilus 
DSM20079
Lactobacillaceae 2.39 68.49 8.70E-05
2.66 78.50 5.88E-06
L. reuteri DSM20016 Lactobacillaceae 3.17 150.57 4.66E-09
1.74 83.60 1.98E-07
L. plantarum 
DSM21074
Lactobacillaceae, L. 
plantarum
2.12 197.32 3.79E-09
2.09 148.35 2.77E-08
C. difficile 
ATCCBAA1382
Clostridium XI, 
Clostridium difficile
1.12 238.87 4.88E-04
0.80 126.38 1.96E-03
C. jejuni ATCC33292 Campylobacter jejuni 0.70 19.89 5.29E-03
0.91 28.44 5.69E-03
Table 2: Specificity test. (Continued)Candela et al. BMC Microbiology 2010, 10:116
http://www.biomedcentral.com/1471-2180/10/116
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order to evaluate the relative abundance detection level of
the HTF-Microbi.Array, LDR-UA experiments were per-
formed on hybridization mixes containing low quantities
of Escherichia coli PCR products and increasing amounts
of human genomic DNA. This is a fundamental issue in
the case of single species present in the gut microbiota at
very low fractional abundance (< 0.1%) [21]. According to
our data, 1 fmol of E. coli amplicon was sufficient (p <
0.005) to be detected in all the tested conditions (from up
to 6.3 μg of human gDNA) (Additional file 4). Consider-
ing the PCR product as a ~1700 bp amplicon, 1 fmol cor-
responds to 1.2 ng and, thus, the sensitivity limit results
0.02%.
V. parvula ATCC10790 Veillonella, Clostridium 
IX
1.12 205.66 1.57E-04
0.99 140.95 1.39E-04
B. breve DSM20091 Bifidobacteriaceae 2.22 570.01 6.22E-05
1.69 289.07 2.72E-04
B. longum ATCC15707 Bifidobacteriaceae, B. 
longum
1.76 341.94 1.64E-03
0.66 134.86 4.26E-02
R. productus ATCC 
23340
Clostridium XIVa 0.64 4.21 1.41E-03
1.06 17.16 1.24E-06
L. salivarius SV2 Lactobacillaceae, L. 
salivarius
0.89 12.23 4.34E-04
0.65 7.27 2.69E-05
E. faecalis ATCC700802 E. faecalis 3.12 306.51 1.09E-03
2.27 217.16 6.56E-03
C. leptum DSM73 Ruminocuccos bromii 
Clostridium IV
2.28 88.89 5.52E-07
1.13 39.86 2.00E-07
R. albus DSM20455 Ruminocuccos albus 
Clostridium IV
1.46 47.05 2.50E-07
1.41 32.01 4.37E-06
Table reporting the results of the tests to assess probe specificity: 28 bacterial DNA targets were chosen to validate the probe pairs. For each 
DNA analyzed we report: probe pair showing significant signals, SNRs, SNRns (see main text for acronym definitions). The p-values of specific 
probes are reported for each duplicate experiment. Where needed (i.e. more than one probe pair was present), data are the average of the 
positive signals (for both SNRs and p-values)
Table 2: Specificity test. (Continued)Candela et al. BMC Microbiology 2010, 10:116
http://www.biomedcentral.com/1471-2180/10/116
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Characterization of the faecal microbiota of eight healthy 
young adults
The HTF-Microbi.Array was applied in a pilot study for
the characterization of the faecal microbiota of eight
young adults. For all subjects faecal DNA was extracted,
total bacterial 16S rRNA amplified, and two separate
LDR-UA experiments were carried out (Additional file 5).
For each sample a profile of presence-absence probes
response was obtained. The cluster analysis of the phylo-
genetic fingerprints showed that, with the exception of
subject n. 2, samples from the same subject clustered
together. The reproducibility of the experiments was
evaluated by considering the percentage of the probes
giving the same response in both the technical replicates
of each sam ple. W it h the e x clusion of subject n. 2, an
average reproducibility of 96% was obtained for all the
subject under study, demonstrating a good reproducibil-
ity of the microbiota fingerprints obtained using the
HTF-Microbi.Array (Fig. 3). As expected, the major
mutualistic symbionts of the human intestinal microbi-
ota, such as Bacteroidetes  and the members of the
Clostridium cluster IV and XIVa, were represented in the
faecal microbiota of all the subjects. With the exception
of B. clausii et rel., minor mutualistic symbionts such as
Actinobacteria, Lactobacillaceae, B. subtilis et rel., Fuso-
bacterium, and Cyanobacteria were detected only in dif-
ferent sub-fractions of the subjects. In particular, subjects
n. 17, 15, 4, and 1 were characterized by the presence of
Fusobacterium. Subjects n. 4, 15 and 17 possessed B. sub-
tilis et rel., while subjects n. 4, 1, 9, 16 and 5 harboured
Cyanobacteria in their faecal microbiota. On the other
hand, only a fraction of the subjects, clustering on the left
side of the map, presented opportunistic pathogens in
their faecal microbiota. Subjects n. 17, 15 and 4 presented
both Proteus and E. faecalis et rel., while in subject n. 15
members of the Clostridium cluster I and II and Yersinia
Figure 2 Complex mix of 16 rRNA amplicons. LDR-universal array experiments carried out on a complex mix of 16 rRNA amplicons obtained from 
six members of the human intestinal microbiota: B. cereus, L. casei, B. adolescentis, R. albus, Prevotella, Y. enterocolitica. Amplicons were tested in a con-
centration ranging from 0.7 to 75 fmol. Blue stars over the fluorescence bars indicate the probes that gave a positive response with a P < 0.01. Red 
dots indicate that one or two replicates out of four for each ZipCode were excluded because of having an IF < 2.5 times the average of the spots.
(B.c-L.c-B.a-R.a-Pr-Y.e) 16S rDNA 0.7 fmol (B.c-L.c-B.a-R.a-Pr-Y.e) 16S rDNA 1.5 fmol (B.c-L.c-B.a-R.a-Pr-Y.e) 16S rDNA 3 fmol
(B.c-L.c-B.a-R.a-Pr-Y.e) 16S rDNA 6 fmol (B.c-L.c-B.a-R.a-Pr-Y.e) 16S rDNA 12 fmol (B.c-L.c-B.a-R.a-Pr-Y.e) 16S rDNA 25 fmol
(B.c-L.c-B.a-R.a-Pr-Y.e) 16S rDNA 50 fmol
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et rel. were also detected. For each subject the relative flu-
orescence intensity (IF) contribution of each HTF-
Microbi.Array probes, in terms of percentage of the total
IF, was also calculated (Fig. 4). The mean of IF data from
both the LDR-UA experiments were considered. Even if
all subjects were characterized by a specific individual
profile, a common trend can be found by comparing the
comprehensive relative IF contribution of probes target-
ing major mutualistic symbionts (Bacteroides/Prevotella,
Clostridium clusters IV, IX, and XIVa), minor mutualistic
symbionts (Bifidobacteriaceae, Lactobacillaceae,  B.
clausii et rel.,  B .  s u b t i l i s  e t  r e l . ,  Fusobacterium, and
Cyanobacteria), and opportunistic pathogens (Clostrid-
ium clusters I and II, IX, E. faecalis et rel., E. faecium et
rel., B. cereus et rel., Enterobacteriaceae, Yersinia, Proteus,
Campylobacter). In particular, for all subjects the highest
relative IF contributions were obtained for major mutual-
istic symbionts. The contribution of Bacteroides/Pre-
votella ranged between 8-37%, whereas the contribution
of Clostridium clusters IV, IX, and XIVa ranged between
17-34%, 3-15%, and 5-29%, respectively. Differently,
minor mutualistic symbionts were characterized by lower
v a l u e s  o f  r e l a t i v e  I F  c o n t r i b u t i o n s .  Bifidobacteriaceae
contributed for the 0.5-3.1%, Lactobacillaceae for the 1.5-
9.4%, B. clausii et rel. for the 4-13%, B. subtilis et rel. for
the 0.6-2.5%, Fusobacterium  for the 1.2-4.4%, and
Cyanobacterium for 0.6-4.5%. As expected, opportunistic
pathogens showed together the lowest relative IF contri-
bution in all the subjects under study (from 5 to 10%).
Discussion
In these last years, 16S rRNA microarrays emerged as a
sensitive and efficient way to screen complex bacterial
communities. Here we describe and validate the HTF-
Microbi.Array, a new phylogenetic DNA microarray
designed for the high taxonomic level fingerprint of the
human intestinal microbial community. The HTF-
Microbi.Array is based on the LDR-UA approach, which
is a fast and sensitive tool for the characterization of com-
plex microbial communities with high sensitivity and
specificity [25,26]. The use of this molecular technique
allows overcoming the major limitations of DNA
microarrays whose discriminative power is based on
hybridization. In fact, a) optimization of the hybridiza-
Figure 3 Phylogenetic fingerprints. Cluster analysis of the phylogenetic fingerprint of 16 faecal samples from 8 young adults. Response of each of 
the HTF-Microbi.Array probes for what concerns presence/absence of the target group is showed: positive response in red (P < 0.01), negative re-
sponses in blue (P > 0.01). Gary lines below the samples indicate adjacent replicated LDR of the same sample.
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tion conditions for each probe set is not required; b)
problems due to the secondary structures of the target
DNA are minimized, c) steric hindrances of differentially
sized nucleic acid hybrids formed on the array after the
hybridization are decreased [29]. The final probe set of
the HTF-Microbi.Array allows a high taxonomic level
fingerprint of the human intestinal microbiota, with a
good coverage of the major and minor components, as
well as some of the most important pathogens and oppor-
tunistic bacteria [30]. The LDR probes were designed by
choosing DS oligonucleotides whose 3'end allowed the
perfect discrimination of the target species from the non-
target ones on the basis of our 16S rRNA sequence data-
base. Definition of accurate and specific negative sets of
gut microbiota sequences by ORMA tool [31] allowed the
selection of maximally discriminative probe pairs. Probe
specificity was confirmed on the entire known 16S rRNA
gene sequences environment by the RDP Probe Match
tool. This requirement is fundamental, since the primer
set used for the PCR amplification was the "universal" 16S
rRNA primer set designed by Edwards and co-workers
[32].
The HTF-Microbi.Array recognized without ambigu-
ity the 16S rRNA amplicons obtained from 28 members
of the intestinal microbiota belonging to Bacteroides/Pre-
votella, Clostridium clusters IV, IX, XIVa, XI, I and II,
Bifidobacteriaceae, Lactobacillaceae, Bacillus, Enterococ-
cus, Enterobacteriaceae and Campylobacter, demonstrat-
ing the specificity of all the probe pairs. The sensitivity of
the HTF-Microbi.Array was evaluated by using different
concentrations of an artificial mix of 16S rRNA ampli-
cons obtained from 6 microorganisms members of the
human intestinal microbiota. To compensate the eventual
drop in the signal due to a very low target concentrations,
lower than 0.7 fmol (i.e. a percentage lower than 1.5% of
the commonly used quantity of 50 fmol), a slightly
relaxed criteria for significance of the t-test to α = 0.05
was chosen. All PCR products were specifically recog-
nized in a concentration range from 75 to 0.7 fmol, show-
ing high array sensitivity. The efficiency of the HTF-
Microbi.Array in the detection of a particular target in a
complex DNA environment was also determined.
According to our data, the array is able to detect a specific
DNA target down to 0.02% of the total 16S rRNA, which
Figure 4 IF relative contribution. For each sample the entire HTF-Microbi.Array probe set was considered and their relative IF contribution was cal-
culated as percentage of the total IF. Sub-probes were excluded and for each subject data from two separate LDR-universal array experiments were 
taken onto consideration. The averaged IF from both the LDR-Universal Array experiments was considered. The principal intestinal groups of major 
mutualistic symbionts are indicated: Bacteroides/Prevotella (B/P) blue, Clostridium cluster IV (Cl.IV) green, Clostridium cluster IX (Cl.IX) brown, Clostridium 
cluster XIVa (Cl.XIVa) dark brown. Lactobacillus, B. clausii, B. subtilis, Fusobacterium and Cyanobacteria are grouped as minor mutualistic symbionts (mi-
nor) indicated in yellow. Proteus, Yersinia and E. faecalis are grouped as opportunistic pathogens (opp) in red.
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is comparable to the values obtained by Rajilic-Stojanovic
et al. [23] and Palmer et al. [21]. Thus the HTF-
Microbi.Array shows the potentiality to sense low abun-
dant species of the gastrointestinal microbiota, enabling
the detection of the 16S rRNA of a peculiar target group
present at a fractional abundance <0.1% in an artificial
mixture.
The HTF-Microbi.Array was used in a pilot study to
characterize the faecal microbiota of eight young adults.
Faecal microbiota was chosen as DNA source since sam-
ple collection is not invasive, samples contain large
amount of microbes, and, most important, it is represen-
tative of interpersonal differences in distal gut microbial
ecology [33]. In order to have a good representation of
the less abundant species of the intestinal microbial com-
munity, LDR reactions were performed starting from 50
fmol of PCR product. Cluster analysis of the presence-
absence probes profiles enabled the identification of a
reproducible high taxonomic level microbiota fingerprint
for each subject. As expected, the intestinal microbial
community of the voluntaries in the study resembled the
typical fingerprint of healthy adults [28]. According to
our data, the faecal microbiota of the enrolled subjects
was dominated by major mutualistic symbionts. In fact,
members of Bacteroidetes, Clostridium clusters IV, IX
and XIVa were all represented in 100% of the subjects. On
the other hand, minor mutualistic symbionts, such as
Lactobacillaceae,  B .  s u b t i l i s  e t  r e . ,  Fusobacterium  and
Cyanobacteria, were detected in 55, 37, 50, and 63% of
the subjects, respectively. Opportunistic pathogens, such
as E. faecalis et rel., members of the Clostridium cluster I
and II and Enterobacteriaceae, were represented only in
43, 25 and 12% of the subjects, respectively. Most impor-
tantly, enteropathogens such as, C. difficile, C. perfrin-
gens,  E. faecium et rel.,  B. cereus et rel., and
Campylobacter  were never detected. A discrepancy
between our data and the literature is the relatively low
prevalence of the health promoting Bifidobacteriaceae in
our samples (only 13% of samples). However, the low
prevalence of bifidobacteria is a typical bias for several
phylogenetic DNA microarrays [22,23]. Probably this is
due to the intrinsic low efficiency of amplification of the
bifidobacterial genome with universal primer sets for the
16S rRNA gene [8]. Surprisingly, a high prevalence was
obtained for the minor mutualistic symbiont B. clausii et
rel., 100% of samples, and the opportunistic pathogen
Proteus, 50% of samples. For each subject the relative IF
contributions of the probes were calculated, obtaining an
approximate evaluation of the relative abundance of the
principal microbial groups of the faecal microbiota. In
general agreement with previous metagenomic studies
[7-11] and SSU rRNA phylogenetic microarray investiga-
tions [22,23], mutualistic symbionts such as Bacteroi-
detes, Clostridium clusters IV, IX and XIVa largely
dominated the faecal microbiota, contributing for the 65
to 80% of total microbiota, depending on the subject. Dif-
ferently, with an overall contribution ranging from 10 to
30%, minor mutualistic symbionts such as B. clausii et
rel., Bifidobacteriaceae,  Lactobacillaceae,  B. subtilis et
rel., Fusobacterium, and Cyanobacteria were largely sub-
dominant. Opportunistic pathogens represented only a
small fraction of the intestinal microbiota. Even if sub-
jects under study show a common trend when the ratio
between the relative IF of major, minor and opportunistic
components were considered, differences in the relative
IF contribution of single probes were detectable and sub-
ject specific profiles were identified. For instance, subject
n. 1 showed a higher relative fluorescence for probes tar-
geting major mutualistic symbionts and a lower relative
fluorescence for minor mutualistic symbionts and oppor-
tunistic pathogens than subjects n. 4 and 15. On the other
hand subjects n. 15 and 17 were characterized by a lower
ratio  Bacteroidetes/Firmicutes  with respect to all the
other subjects. It is tempting to hypothesize that differ-
ences in relative IF contribution within samples could
represent an approximation of differences in relative
abundances of the targeted groups in the faecal microbi-
ota. However, caution must be taken when microarray
based methods for the relative quantification of bacterial
groups in complex microbial communities are used. In
fact, biases are introduced at several levels of the experi-
mental procedure: DNA extraction and purification, PCR
amplification of the 16S rRNA gene, and interspecies
variation of the rRNA gene copy number [21].
Conclusion
The HTF-Microbi.Array has been revealed a fast and sen-
sitive tool for the high taxonomic level fingerprint of the
human intestinal microbiota in terms of presence/
absence of the principal groups. Since the flexibility of the
universal array platform allow the addition of new probe
pairs without a further optimization of the hybridization
conditions [25,26], the HTF-Microbi.Array can be easy
implemented with the addition of new probe pairs target-
ing emerging microbial groups of the human intestinal
microbiota, such as, for instance, the mucin degrading
bacterium Akkermansia muciniphila [34]. The evaluation
of the relative abundance of the target groups on the
bases of the relative IF probes response still has some hin-
drances. However, considered all the possible biases (i.e.
DNA extraction/purification, PCR, copy number varia-
tions, etc.) typical of the microarray technology, analysis
of IFs from our LDR-UA platform can be useful in the
estimation of the relative abundance of the targets groups
within each sample. Focusing the phylogenetic resolution
at division, order and cluster levels, the HTF-
Microbi.Array results blind with respect to the inter-indi-
vidual variability at the species level. Its potential to char-Candela et al. BMC Microbiology 2010, 10:116
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acterize the high order taxonomic unbalances of the
human intestinal microbiota associated with specific dis-
eases will be assessed in further studies.
Methods
Recruitment
Eight healthy Italian individuals of 30 years old were
enrolled for the study. None of the subjects had dietary
restrictions except for antibiotics, probiotics and func-
tional foods for at least 4 weeks prior to sampling. None
of the selected subjects had a history of gastrointestinal
disorders at the time of sampling. The study protocol was
approved by the Ethical committee of Sant'Orsola-Mal-
pighi Hospital (Bologna, Italy) and an informed consent
was obtained from each enrolled subject. Faeces were
collected for each subject and stored at -20°C.
Bacterial strains and culture conditions
The bifidobacterial strains used in this study were Bifido-
bacterium adolescentis ATCC15703,  B. bifidum
DSM20456, B. breve DSM20091, B. longum ATCC15707.
The Lactobacillus strains were Lactobacillus plantarum
DSM21074, L. casei DSM20011, L. ramnosus DSM20021,
L. salivarius SV2 (strain from our collection), L. del-
brueckii  DSM 20314, L. gasseri DSM20243,  L. reuteri
DSM20016,  L. pentosus DSM20134,  L. acidophilus
DSM20079. All bifidobacteria and Lactobacillus strains
were grown on De Man-Rogosa-Sharpe (MRS) broth
with cysteine (0.5 g/l) at 37°C under an anaerobic atmo-
s p h e r e  ( A n a e r o c u l t ,  M e r c k ,  D a r m s t a d t ,  G e r m a n y ) .
Escherichia coli ATCC11105 was cultivated at 37°C aero-
bically on TY-broth. Salmonella cholerasuis typhimurium
and  Yersinia enterocolitica-type, kindly provided by A.
Essig, Dept. of Medical Microbiology, University of Ulm,
G e r m a n y ,  w e r e  c u l t i v a t e d  a e r o b i c a l l y  a t  3 0 ° C  o n  B H I -
broth.
Target selection and consensus extraction
A database of 16S rRNA sequences was created by inte-
gration of the 16S rRNA database of the ARB Project
(release February, 2005) (http://www.arb-home.de; [35])
with the database of the Ribosomal Database Project
(RDP; release September, 2007) (http://rdp.cme.msu.edu/
; [36,37]). A phylogenetic tree was obtained in the ARB
software, by using the neighbour-joining algorithm for
the sequence alignment. The tree was used for the ratio-
nal selection of phylogenetically related groups of bacte-
ria belonging to the human intestinal microbiota which
correspond to nodes of the phylogenetic tree (Additional
file 1). Group specific consensus sequences were
extracted, with a cut-off of 75% for base calling. Nucle-
otides which occurred at lower frequencies were replaced
by the appropriate IUPAC ambiguity code.
Probe design
Multiple alignment step of the selected sequences was
performed in ClustalW [38]. Since the taxonomic classifi-
cation of the 30 groups selected for the probe design var-
ied from species to phylum level, careful grouping of the
sequences was performed for the multiple alignment
step: (a) for higher level probes, only family/phylum con-
sensus sequences were used as a negative set for probe
design; (b) for genus/species level probes, only sequences
belonging to other families/phyla were selected. All the
LDR probe pairs were designed using ORMA [31]. Both
DS and CP were required to be between 25 and 60 bases
pair, with a Tm of 68 ± 1°C, and with maximum 4 degen-
erated bases. In-silico  check versus a publicly available
database (i.e.: RDP) was then performed for assessing
probe pair specificity.
DNA extraction
Total DNA was extracted from 109 bacterial cells by using
the DNeasy Tissue Kit 50 (Quiagen, Düsseldorf, Ger-
many) following the manufacturer instructions. Bacterial
DNA was also extracted from lyophilized bacterial cells
of the following DSMZ (Braunschweig, Germany) collec-
tion strains: Clostridium leptum DSM73, Ruminococcus
albus  DSM20455, Eubacterium siraeum DSM15700, C.
viride  DSM6836,  Megasphera micrinuciformis
DSM17226,  Bacillus clausii DSM2515,  B. subtilis
DSM704,  B. cereus DSM21, and Proteus mirabilis
DSM4479. Lyophilized bacterial cells were suspended in
1 ml of lysis buffer (500 mM NaCl, 50 mM Tris-HCl pH 8,
50 mM EDTA, 4% SDS) and DNA extraction was carried
out by employing the same procedure used for the extrac-
tion of genomic DNA from faecal samples, according to
the following procedure. Total DNA from faecal material
was extracted using QIAamp DNA Stool Min Kit (Qia-
gen) with a modified protocol. 250 mg of faeces were sus-
pended in 1 ml of lysis buffer. Four 3 mm glass beads and
0.5 g of 0.1 mm zirconia beads were added, and the sam-
ples were treated in FastPrep (MP Biomedical, Irvine,
CA, USA) at 5.5 ms for 3 min. Samples were heated at
95°C for 15 minutes, then centrifuged for 5 min at full
s p e e d  t o  p e l l e t  s t o o l  p a r t i c l e s .  S u p e r n a t a n t s  w e r e  c o l -
lected and 260 μl of 10 M ammonium acetate were added,
followed by incubation in ice for 5 min and centrifugation
at full speed for 10 min. One volume of isopropanol was
added to each supernatant and incubated in ice for 30
min. The precipitated nucleic acids were collected by
centrifugation for 15 min at full speed and washed with
70% ethanol. Pellets were resuspended in 100 μl of TE
buffer and treated with 2 μl of DNase-free RNase (10 mg/
ml) at 37°C for 15 min. Protein removal by Proteinase K
treatment and DNA purification with QIAamp Mini Spin
columns were performed following the kit protocol. 200
μl of TE buffer were used for DNA elution. Final DNACandela et al. BMC Microbiology 2010, 10:116
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concentration was determined by using NanoDrop ND-
1000 (NanoDrop Technologies, Wilmington, DE). The
bacterial DNA from the following 11 ATCC strains was
directly obtained from the ATCC: Bacteroides fragilis
ATCC25285, B. thetaiotaomicron ATCC29148, Prevotella
melaninogenica  ATCC25845,  Veilonella parvula
ATCC10790, C. difficile ATCCBAA1382, C. acetobutili-
cum ATCC824, C. perfringens ATCC13124, Enterococcus
faecalis ATCC700802, E. faecium ATCC51559, Campy-
lobacter jejuni ATCC33292, R. productus 23340.
Polymerase Chain Reaction (PCR)
All the oligonucleotide primers and probe pairs were syn-
thesized by Thermo Electron (Ulm, Germany). PCR
amplifications were performed with Biometra Thermal
Cycler II and Biometra Thermal Cycler T Gradient
(Biometra, Germany). PCR products were purified by
using a Wizard SV gel and PCR clean-up System purifica-
tion kit (Promega Italia, Milan, Italy), according to the
manufacturer's instructions, eluted in 20 μl of sterile
water, and quantified with the DNA 7500 LabChip Assay
kit and BioAnalyzer 2100 (Agilent Technologies, Palo
Alto, CA, USA). 16S rRNA was amplified using universal
forward primer 16S27F (5'-AGAGTTTGATCMTGGCT-
CAG-3') and reverse primer r1492 (5'-TACGGYTACCT-
TGTTACGACTT-3'), following the protocol described in
Castiglioni et al. [25] except for using 50 ng of starting
DNA and 0.5 U of DNAzyme DNA polymerase II
(Finnzymes, Espoo, Finland).
LDR/Universal Array approach
Phenylen-diisothiocyanate (PDITC) activated chitosan
glass slides were used as surfaces for the preparation of
universal arrays [39], comprising a total of 49 Zip-codes.
Hybridization controls (cZip 66 oligonucleotide, comple-
mentary to zip 66, 5'-Cy3-GTTACCGCTGGTGCTGC-
C G C C G G T A - 3 ' )  w e r e  u s e d  t o  l o c a t e  t h e  s u b m a t r i x e s
during the scanning. The entire experimental procedure
for both the chemical treatment and the spotting is
described in detail in Consolandi et al. [40]. An overview
of the Universal Array layout and ZipCodes is provided as
Additional file 6. Ligase Detection Reaction and hybrid-
ization of the products on the universal arrays were per-
formed according to the protocol described in Castiglioni
et al. [25], except for the probe annealing temperature, set
at 60°C.
The LDRs were carried out in a final volume of 20 μl
with different quantities of purified PCR products: a) all
LDRs for specificity tests were performed on 50 fmol of
initial PCR product, for having no issues related to target;
b) sensitivity tests were performed with decreasing PCR
product concentration from 75 to 0.7 fmol; c) relative
abundance tests were performed on 1 fmol E. coli PCR
amplicon, mixed with human genomic DNA extracted
from whole blood, at decreasing concentrations, from 4%,
down to 0.02%; d) LDR experiments on the eight faecal
samples were performed on 50 fmol of PCR product.
Data analysis
All arrays were scanned with ScanArray 5000 scanner
(Perkin Elmer Life Sciences, Boston, MA, USA), at 10 μm
resolution. In the experiments, the fluorescent images
were obtained with different acquisition parameters on
both laser power and photo-multiplier gain, in order to
avoid saturation. IF were quantitated by ScanArray
Express 3.0 software, using the "Adaptive circle" option,
letting diameters vary from 60 to 300 μm. No normaliza-
t i o n  p r o c e d u r e s  o n  t h e  I F s  h a v e  b e e n  p e r f o r m e d .  T o
assess whether a probe pair was significantly above the
background (i.e. was "present" or not), we performed a
one-sided t-test (α = 0.01). The criteria was relaxed to α =
0.05 for sensitivity tests. The null distribution was set as
the population of "Blank" spots (e.g. with no oligonucle-
otide spotted, n = 6). Two times the standard deviation of
pixel intensities of the same spots was added to obtain a
conservative estimate. For each zip-code, we considered
the population of the IFs of all the replicates (n = 4) and
tested it for being significantly above the null-distribution
(H0: μtest = μnull; H1: μtest>μnull). In case one replicate in the
test population was below 2.5 times the distribution
mean, this was considered an outlier and was discarded
from the analyses. We calculated the ratio between the
signal intensities of the specific probes on the blank
intensity (SNRs) and the ratio between all the other
probes and the blank intensity (SNRns).
Clustering
Hierarchical clustering of HTF-Microbi.Array profiles
was carried out using the statistical software R http://
www.r-project.org. The Euclidean distance among sam-
ple profiles was calculated and Ward's method was used
for agglomeration.
Additional material
Additional file 1 HTF-Microbi.Array target groups. Phylogenetically 
related groups target of the HTF-Microbi.Array.
Additional file 2 HTF-Microbi.Array probe list. Table of the 30 designed 
probe pairs. Sequences (5' -> 3') for both DS and CP are reported, as well as 
major thermodynamic parameters (melting temperature, length, number 
of degenerated bases).
Additional file 3 Specificity tests of the HTF-Microbi.Array. Raw data of 
the specificity tests of the HTF-Microbi.Array. Each column represent a dif-
ferent sample, whose identification is reported as its label. On the left, the 
ZipCode, the probe name and ID are reported. "Type" is a numeric flag used 
for the classification of the probes: 1 is the hybridization control, 2 is the 
ligation control, 3 indicates the HTF-Microbi.Array probes, 4 are the unused 
ZipCodes and 5 is the Blank. "Numeric ID" is given to the probes according 
to their "type" and "Oligo ID" values.Candela et al. BMC Microbiology 2010, 10:116
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